NCT05614973

Brief Summary

A prospective, randomized, two-arm, single-center study to compare efficacy and safety of percutaneous ultrasound-guided liver biopsy of conventional method (multiple liver punctures) versus coaxial method followed by needle tract plugging.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 1, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

November 14, 2022

Status Verified

November 1, 2022

Enrollment Period

1.1 years

First QC Date

November 1, 2022

Last Update Submit

November 10, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Safety of percutaneous liver biopsy

    Biopsy-related bleeding * Minor bleeding is defined as presence of linear flow signal along the needle tract on Doppler exam. * Major bleeding is defined as bleeding which requires transfusion or vascular embolization.

    During procedure

  • Safety of percutaneous liver biopsy

    Biopsy-related bleeding * Minor bleeding is defined as presence of linear flow signal along the needle tract on Doppler exam. * Major bleeding is defined as bleeding which requires transfusion or vascular embolization.

    Day 1 after procedure

  • Safety of percutaneous liver biopsy

    Biopsy-related bleeding * Minor bleeding is defined as presence of linear flow signal along the needle tract on Doppler exam. * Major bleeding is defined as bleeding which requires transfusion or vascular embolization.

    Day 7 after procedure

Secondary Outcomes (1)

  • Efficacy of percutaneous liver biopsy

    1 week

Study Arms (2)

Conventional

ACTIVE COMPARATOR

Percutaneous liver biopsy is carried out through multiple punctures of liver capsule.

Procedure: Conventional method

Coaxial/plugging

EXPERIMENTAL

Percutaneous liver biopsy is carried out through single puncture of liver capsule using coaxial needle and subsequent needle tract plugging.

Procedure: Coaxial method with needle-track plugging

Interventions

The conventional method utilizes a 18G biopsy gun to acquire three or more tissue cores with the corresponding number of liver capsule punctures. Plugging of the biopsy needle track is not performed.

Conventional

The coaxial method utilizes a 17G coaxial needle with 18G biopsy gun to acquire three or more tissue cores with a single liver capsule puncture. Biopsy needle track is plugged using a slurry of gelatin particles (EGgel S Plus 2000-4000 μm).

Coaxial/plugging

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adult patients aged 19 years or older in this institution
  • Patients referred for imaging-guided percutaneous liver biopsy requiring three or more tissue cores
  • Patients who understand and consent to enrollment in this study
  • Target lesion diameter 1cm or larger, and the lesion is approachable under ultrasonography-guidance.

You may not qualify if:

  • Patients with severe psychologic disorder or mental retardation
  • Patients with poor cooperation
  • Severe coagulopathy
  • Hepatobiliary obstruction
  • Acute hepatobiliary infection
  • Large amount of ascites
  • Amyloidosis
  • Patients on antiplatelet/anticoagulant medication that cannot be discontinued for a specified period of time
  • Other patients whom the researchers deem ineligible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yonsei University Health System, Severance Hospital

Seoul, South Korea

RECRUITING

Study Officials

  • Seung-seob Kim

    Severance hospitalDepartment of Radiology, Severance Hospital, Yonsei University College of Medicine, Korea

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seung-seob Kim

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Enrolled patients will be randomly allocated to either the conventional group or coaxial/plugging group for percutaneous liver biopsy. After the procedure, the rates of biopsy-related complications as well as diagnostic yield will be compared.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2022

First Posted

November 14, 2022

Study Start

August 2, 2022

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

November 14, 2022

Record last verified: 2022-11

Locations